US 10870652
Compounds and methods for modulating bruton's tyrosine kinase
granted A61PA61P29/00A61P35/00
Quick answer
US patent 10870652 (Compounds and methods for modulating bruton's tyrosine kinase) held by Corvus Pharmaceuticals, Inc. expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corvus Pharmaceuticals, Inc.
- Grant date
- Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P37/02